Business Standard

Monday, December 23, 2024 | 10:07 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Nifty Pharma index up 11% from May's low

At 12:05 pm; the Nifty Pharma index was up 1.3% at 9,703, surging 11% from 8,758 hit on May 29, 2017

pharma, pharma industry
Premium

Govt proposes to bring fixed-dose combinations under price control

SI Reporter Mumbai
Shares of pharmaceutical companies were back in focus with Nifty Pharma index rallying more than 10% from its May’s low, while Nifty 50 index remain unchanged during the same period.

In the last three days, Aurobindo Pharma, Cadila Healthcare and Sun Pharmaceutical Industries received  the US Food and Drug Administration (USFDA) approval for their respective drugs, while Dr Reddy’s Laboratories received Establishment Inspection Report (EIR) from the US health regulator for its Miryalaguda plant.

At 12:05 pm; the Nifty Pharma index, the largest gainer among sectoral indices, was up 1.3% at 9,703. The index surged 11% from its

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in